0001062993-21-002721.txt : 20210315 0001062993-21-002721.hdr.sgml : 20210315 20210315171238 ACCESSION NUMBER: 0001062993-21-002721 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210312 FILED AS OF DATE: 20210315 DATE AS OF CHANGE: 20210315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Uger Robert CENTRAL INDEX KEY: 0001838047 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36596 FILM NUMBER: 21742419 MAIL ADDRESS: STREET 1: C/O TRILLIUM THERAPEUTICS INC. STREET 2: 2488 DUNWIN DRIVE CITY: MISSISSAUGA STATE: A6 ZIP: L5L 1J9 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Trillium Therapeutics Inc. CENTRAL INDEX KEY: 0001616212 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2488 DUNWIN DRIVE CITY: MISSISSAUGA STATE: A6 ZIP: L5L 1J9 BUSINESS PHONE: (416) 595-0627 MAIL ADDRESS: STREET 1: 2488 DUNWIN DRIVE CITY: MISSISSAUGA STATE: A6 ZIP: L5L 1J9 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2021-03-12 0001616212 Trillium Therapeutics Inc. TRIL 0001838047 Uger Robert C/O TRILLIUM THERAPEUTICS INC. 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 ONTARIO, CANADA 0 1 0 0 Chief Scientific Officer Common Shares 2021-03-12 4 M 0 2917 3.3924 A 2917 D Common Shares 2021-03-12 4 S 0 2917 11.97 D 0 D Stock Option (Right to Buy) 3.3924 2021-03-12 4 M 0 2917 0 D 2028-11-08 Common Shares 2917 58333 D This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. The exercise price of these options is $4.23 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.8020 USD. 25% of the options vest on the one year anniversary of the grant date and the remaining options vest in equal monthly installments over the following 36 months. /s/ James Parsons, Attorney-in-Fact 2021-03-15